These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 22293328)
1. Role of serological markers of activated eosinophils in inflammatory bowel diseases. Dainese R; Galliani EA; De Lazzari F; D'Incà R; Mariné-Barjoan E; Vivinus-Nebot MH; Hébuterne X; Sturniolo GC; Piche T Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):393-7. PubMed ID: 22293328 [TBL] [Abstract][Full Text] [Related]
2. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314 [TBL] [Abstract][Full Text] [Related]
3. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study. Wagner M; Peterson CG; Stolt I; Sangfelt P; Agnarsdottir M; Lampinen M; Carlson M Scand J Gastroenterol; 2011 Jul; 46(7-8):849-54. PubMed ID: 21557718 [TBL] [Abstract][Full Text] [Related]
4. Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed. Blom K; Rubin J; Halfvarson J; Törkvist L; Rönnblom A; Sangfelt P; Lördal M; Jönsson UB; Sjöqvist U; Håkansson LD; Venge P; Carlson M World J Gastroenterol; 2012 Nov; 18(44):6409-19; discussion p. 6417-8. PubMed ID: 23197886 [TBL] [Abstract][Full Text] [Related]
5. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313 [TBL] [Abstract][Full Text] [Related]
6. Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer. Aydemir SA; Tekin IO; Numanoglu G; Borazan A; Ustundag Y Mediators Inflamm; 2004 Dec; 13(5-6):369-72. PubMed ID: 15770055 [TBL] [Abstract][Full Text] [Related]
8. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis. Oh JW; Shin JC; Jang SJ; Lee HB Ann Allergy Asthma Immunol; 1999 Jun; 82(6):579-85. PubMed ID: 10400487 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis. Scavuzzo MC; Fattori B; Ruffoli R; Rocchi V; Carpi A; Berni R; Giambelluca MA; Giannessi F Biomed Pharmacother; 2005 Jul; 59(6):323-9. PubMed ID: 15935609 [TBL] [Abstract][Full Text] [Related]
10. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Carlson M; Raab Y; Peterson C; Hällgren R; Venge P Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252 [TBL] [Abstract][Full Text] [Related]
11. Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea. Wagner M; Sjöberg K; Vigren L; Olesen M; Benoni C; Toth E; Carlson M Scand J Gastroenterol; 2016 Jul; 51(7):835-41. PubMed ID: 26854205 [TBL] [Abstract][Full Text] [Related]
12. Atopy, IgE and eosinophilic cationic protein concentration, specific IgE positivity, eosinophil count in cutaneous T Cell lymphoma. Kural YB; Su O; Onsun N; Uras AR Int J Dermatol; 2010 Apr; 49(4):390-5. PubMed ID: 20465692 [TBL] [Abstract][Full Text] [Related]
13. [The relationship between skin test results and serum eosinophilic cationic protein, nasal eosinophilia, and total IgE values in patients with allergic rhinitis]. Pinar E; Bolat F; Oncel S; Köseoğlu M; Yüksel H; Calli C Kulak Burun Bogaz Ihtis Derg; 2005; 14(5-6):101-5. PubMed ID: 16340277 [TBL] [Abstract][Full Text] [Related]
14. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331 [TBL] [Abstract][Full Text] [Related]
15. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity. Kim CK; Callaway Z; Fletcher R; Koh YY J Asthma; 2010 Jun; 47(5):568-73. PubMed ID: 20560830 [TBL] [Abstract][Full Text] [Related]
16. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Kristjánsson G; Venge P; Wanders A; Lööf L; Hällgren R Gut; 2004 Dec; 53(12):1806-12. PubMed ID: 15542519 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of eosinophil cationic protein levels with clinical symptoms and laboratory findings of patients with cystic echinococcosis]. Cicioğlu Aridoğan B; Kaya S; Sesli Cetin E; Taş T; Demirci M Mikrobiyol Bul; 2009 Apr; 43(2):285-92. PubMed ID: 19621614 [TBL] [Abstract][Full Text] [Related]
19. Measurements of eosinophil activation before and after food challenges in adults with food hypersensitivity. van Odijk J; Peterson CG; Ahlstedt S; Bengtsson U; Borres MP; Hulthén L; Magnusson J; Hansson T Int Arch Allergy Immunol; 2006; 140(4):334-41. PubMed ID: 16757922 [TBL] [Abstract][Full Text] [Related]
20. Serum levels of eosinophil cationic protein and eosinophil protein x in pollen atopic patients with stable asthma and its relation with bronchial hyperresponsiveness. Chivato T; Martínez D; Blasco R; Melgarejo M; Gómez de Terreros FJ; Laguna R Allergol Immunopathol (Madr); 1996; 24(6):243-7. PubMed ID: 9010559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]